Infinium Global Research Conjunctivitis Market | Page 3

Segment Covered
The report on global conjunctivitis market covers segments such as, disease type. On the basis of disease type
the global conjunctivitis market is categorized into bacterial conjunctivitis, viral conjunctivitis and allergic
conjunctivitis.
Geographic Coverage
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and
Rest of the World. In this section the key trends and market size for each geography is provided over the
period of 2015-2023.
The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific
includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France,
Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North
America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for
the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to
experience a growth at a CAGR of x.x% over the period of 2017-2023.
Companies Profiled:
The report provides profiles of the companies in the global conjunctivitis market such as, Akorn, Alcon,
Allergan, Inc., Bausch & Lomb, Eleven Biotherapeutics, Griffin Discoveries, InSiteVision, Nicox, NovaBay and
Ocular Therapeutix.
Report Highlights:
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In
addition, this report provides insights on the factors that are driving and restraining the global conjunctivitis
market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas
that existing or new market players can consider. The report provides insights into the market using analytical